United States: Mintz IRA Update — Legal Challenges To The Medicare Drug Price Negotiation Program Continue - Mintz
Monday, 4 March 2024 The IRA's Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program"), which aims to lower drug prices by enabling the federal government to negotiate prices...
Latest Weight-Loss Drug , Faces Shortages .
The United States Food and Drug Administration
(FDA) says that high demand has left the latest
weight-loss drug, Zepbound, in short supply.
'Newsweek'..
Credit: Wibbitz Top Stories Duration: 01:30Published
The Committee Study of the Central Intelligence Agency's Detention and Interrogation Program is a report compiled by the bipartisan United States Senate Select Committee on Intelligence (SSCI)..
Drug Shortages Reach , All-Time High in US, , Pharmacists Say.
According to the American Society of Health-System Pharmacists (ASHP) and
the Utah Drug Information Service.
the first quarter of 2024..
Credit: Wibbitz Top Stories Duration: 01:31Published
On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price... Mondaq